Mitchel Sayare

Xenogen Corp. provides real time in-vivo imaging services and genetic modification technologies. Its products and technologies include an imaging system, software, and biological materials. Its solutions are designed to improve discovery and pre-clinical research in multiple therapeutic areas. The company was founded by Pamela Reilly Contag and Christopher H. Contag in 1995 and is headquartered in Alameda, CA.

Theraclone Sciences, Inc. develops novel therapeutic antibodies for the treatment of cancer and infectious diseases. The firm leverages its proprietary antibody discovery technology, I-STARTM to identify rare fully human antibodies from immunologically relevant human subjects. The firm’s primary research focus is to discover novel targets and antibodies, and develop therapeutic monoclonal antibodies, by using its proprietary B-cell technology platform to mine the immune system of cancer patients. The company was founded by Johnny T. Stine in November 2004 and is headquartered in Seattle, WA.

Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.

Isabella Products, Inc. develops wireless products. It offers Vizit, a two-way wireless digital photo frame, enables consumers to interact with billions of unshared images found within camera phones, computers, and the internet by combining touch screen display with wireless network capabilities, and Fable, a seven inch browser tablet built on an android operating system designed for children. The company was founded by Matthew I. Growney and is headquartered in Concord, MA.

CymoGen Dx, LLC provided genomic-based reagents and fluorescent in-situ hybridization probes research products and solutions. The company was headquartered in New Windsor, NY.

Boston IVF, Inc. operates fertility clinics which offer reproductive technologies. The firm's services include IVF laboratory, consultations and evaluations, blood/ultrasound cycle monitoring, Semen analysis, IUI, hysterosalpingogram, Saline Infused Sonogram, patient education, Domar center for mind/body health and acupuncture. The company was founded by Merle Berger and Michael Alper in 1986 and is headquartered in Waltham, MA.